Beste Immunologen - TOP-227 Ärzte

Eli Shpreher ist Leiter der Abteilung für Dermatologie am Ichilov Medical Center – Sourasky.

Stelle im Krankenhaus:

• Leiter der Abteilung für Allergie und klinische Immunologie
• Leiter des Labors für klinische Immunologie am Medizinischen Zentrum Ichilov (Sourasky)

Schwerpunkte der Spezialisierung:

• Klinische und pädiatrische Immunologie,
• Behandlung aller Arten von Allergien,
• Asthmabehandlung,
• Pädiatrische Pneumologie

Ausbildung und klinische Erfahrung:

• Hebräische Universität Jerusalem - Absolvent der Medizinischen Fakultät,
• Hebräische Universität Jerusalem - Spezialisierung auf Pädiatrie,
• Clinic "Sinai" in New York (USA) - Praktikum in der Pädiatrie,
• Hebräische Universität Jerusalem - Spezialisierung in Immunologie und Allergologie,
• National Jewish Clinic in Denver (USA) - Spezialisierung auf Immunologie und Allergologie.

Mitgliedschaft in Berufsverbänden:

• Mitglied der American Association of Clinical Immunologists,
• Mitglied der Israeli Association of Clinical Immunologists,
• Mitglied der International Association of Allergists,
• Mitglied der American Academy of Allergy and Clinical Immunology.

• Experte für Immunologie, spezialisiert auf innovative Immuntherapie-Behandlungen.
• Internationale Praxis in Deutschland; Ausbildung in Hämatologie und Immunologie.
• Aktives Mitglied der Deutschen Gesellschaft für Onkologie und Hämato-Onkologie GDHO.
• Mitwirkender in wissenschaftlichen Zeitschriften im Bereich der Krebsforschung.
• 2010 Zertifizierung als Hämatologe, Onkologe und Immunologe.
• Chefarzt der Klinik für Pneumologie Köln mit Schwerpunkt Immunologie.
• Hat eine Spezialisierung auf Genetik und verbessert die Präzision in der Immuntherapie.
• Leiter der Abteilung für Hämatologie, Onkologie und Palliativmedizin am BKZ Solingen.
• Mitglied der American Society for Cancer Research, Schwerpunkt Immuntherapie.
• Bietet Online-Konsultationen für Patienten, die immunologische Behandlungen benötigen.

EXPERIENCE*

2019 - Present, Istanbul/Istanbul/Turkey

MEMORIAL ATAŞEHİR HOSPITAL

General Surgeon

2012 - 2019, Diyarbakır/Diyarbakır/Turkey

DİCLE UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2011 - 2012, Van/Van/Turkey

VAN REGIONAL TRAINING AND RESEARCH HOSPITAL

General Surgeon

2009 - 2011, Van/Van/Turkey

HAKKARİ STATE HOSPITAL

General Surgeon

2004 - 2009, Van/Van/Turkey

YÜZÜNCÜYIL UNIVERSITY FACULTY OF MEDICINE

General Surgeon

2002 - 2004, Van/Van/Turkey

HACIBEKİR HEALTH CENTER

General Practitioner

*EDUCATION*

2018 - 2019, Diyarbakır/Turkey

Associate Professor

2015, Ohio/USA

OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER

Neck Dissection Training

2012 - 2018, Diyarbakır/Turkey

Assistant Professor

1996 - 2002, Adana/Turkey

ÇUKUROVA UNIVERSITY

FACULTY OF MEDICINE - Medical Doctor Education

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21